Name
Capella University
NURS-FPX4045 Nursing Informatics: Managing Health Information and Technology
Prof. Name
Date
The annotated bibliography was chosen because insulin pump therapy is increasingly becoming important in the treatment of Type 1 and advanced Type 2 Diabetes, especially in patients who need an accurate delivery of insulin and constant monitoring. The technology offers programmable subcutaneous insulin infusion that occurs throughout the day thus enhancing glycemic control, lowering the incidences of hypoglycemic events. In the SentinelU Telehealth Nursing Simulation, the uses of insulin pump were illustrated in the management of William Townsend who had diabetes, obesity and hypertension. His condition indicates that insulin pump therapy allows remote management, patient self-management, and care coordination.
The literature search was done by using the academic databases available in the Capella University Library, ScienceDirect, CINAHL, PubMed, and ProQuest Nursing. The key words used were insulin pump therapy, insulin pump and telehealth, insulin pump in nursing practice, diabetes management technology and continuous insulin infusion. Only peer-reviewed full-text articles published in the past five years were considered to guarantee their reliability and relevance.
It was assumed that insulin pump technology would lead to improved glycemic control by delivering continuous and accurate doses of insulin, thereby minimizing the risks of hypoglycemia and hyperglycemia. The technology was also expected to enhance patient adherence and autonomy by simplifying daily diabetes management tasks as in case of William Townsend. Additionally, it was assumed that telehealth platforms could effectively support remote monitoring of insulin pump data, allowing for timely adjustments and interventions by healthcare providers. Integration of insulin pump data into electronic medical records was presumed to facilitate communication among the care team and streamline decision-making.
Johan J., & Reznik, Y. (2023). Use of insulin pumps and closed‐loop systems among people living with diabetes: A narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers. Diabetes Obesity and Metabolism, 25(S2), 21–32. https://doi.org/10.1111/dom.15087
This article highlights the clinical and economic effect of insulin pumps and hybrid closed-loop (HCL) systems in diabetes management, including type 1 and type 2 diabetes. It highlights the fact that the use of continuous subcutaneous insulin infusion (CSII) and automated insulin delivery have become the norm of type 1 diabetes, but it also shows that their effectiveness in type 2 diabetes is increasingly evidenced. The advantages outlined in the review include better glycemia, lower insulin doses, and no impact on weight, particularly when HCL systems are used.
Notably, it also provides the results of cost-effectiveness, which demonstrate that insulin pump therapy increases quality-adjusted life-years and is affordable in different healthcare systems. This resource can assist nurses and interdisciplinary teams to integrate the use of insulin pumps in chronic diseases management and telehealth interventions, providing information on the customized care planning, access to technology, and policy formulation. The article was chosen because of its detailed analysis of clinical and economic outcomes, which are crucial in the guidance of practice, reimbursement, and future guideline development of technology use in type 2 diabetes.
Yeh, T., Yeung, M., & Mendelsohn Curanaj, F. A. (2021). Managing patients with insulin pumps and continuous glucose monitors in the hospital: To wear or not to wear. Current Diabetes Reports, 21(2), 7. https://doi.org/10.1007/s11892-021-01375-7
This article is a review of the use of insulin pumps and continuous glucose monitors (CGMs) in the management of hospitalized patients with diabetes, and its increasing importance with the increasing prevalence of diabetes and the number of hospitalizations. It examines the present guidance and evidence on the safe continuation of these technologies during inpatient treatment, especially in selected patients with institutional procedures in hand.
The review highlights that euglycemia during hospitalization lowers complications, morbidity and mortality. The CGMs were particularly useful during the COVID-19 pandemic, as they allowed to manage hyperglycemia and minimize staff exposure. To nurses and interdisciplinary teams, this resource points to the importance of being familiar with diabetes technologies in order to use them safely and effectively in the inpatient setting. It has been selected due to its practical nature of incorporating CGMs and insulin pumps into hospital practice, so it is a necessary device to improve glycemic control, improve outcomes, and assist provider education in acute care.
Pauley, M. E., Tommerdahl, K. L., Snell-Bergeon, J. K., & Forlenza, G. P. (2022). Continuous glucose monitor, insulin pump, and automated insulin delivery therapies for type 1 diabetes: An update on potential for cardiovascular benefits. Current Cardiology Reports, 24(12), 2043–2056. https://doi.org/10.1007/s11886-022-01799-x This article explores the potential cardiovascular benefits of diabetes technologies—namely insulin pumps, CGMs, and automated insulin delivery systems—in managing Type 1 Diabetes (T1D). It emphasizes how these technologies improve glycemic trends and may reduce both acute and chronic cardiovascular complications, such as hypertension and arterial stiffness, thereby lowering all-cause mortality.
The review is particularly valuable for interdisciplinary teams—including endocrinologists, cardiologists, diabetes educators, and nurses—who collaborate to manage complex cases of T1D. It highlights how coordinated care involving these professionals can optimize the use of insulin pump therapy to support cardiovascular health. This source was selected for its relevance in demonstrating the broader, long-term advantages of insulin pump therapy beyond glycemic control as in case of William who suffers from multiple chronic diseases. It reinforces the importance of incorporating advanced diabetes technologies into clinical practice, supporting nurses and healthcare professionals in promoting device use to improve overall patient outcomes and reduce cardiovascular risks.
Marks, B. E., Williams, K. M., Sherwood, J. S., & Putman, M. S. (2022). Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems. Journal of Clinical & Translational Endocrinology, 27, 100282. https://doi.org/10.1016/j.jcte.2021.100282
This article reviews the practical use of diabetes technologies—CGMs, insulin pumps, and automated insulin delivery (AID) systems—with a focus on their application in patients with cystic fibrosis-related diabetes (CFRD). While these technologies are proven to enhance glycemic control and quality of life in individuals with type 1 diabetes, their effectiveness in CFRD is less established due to unique physiological and healthcare challenges. The article notes that CGMs are accurate and helpful in CFRD, while insulin pumps may improve lean body mass and HbA1c levels.
It also highlights promising results from early studies using AID systems in this population. From an interdisciplinary perspective, the article underscores the need for collaborative care among endocrinologists, pulmonologists, diabetes educators, pharmacists, and nurses to overcome barriers such as cost, insurance coverage, and device education. This source is especially relevant to nursing and interdisciplinary teams aiming to support the broader implementation of diabetes technologies in complex chronic conditions like CFRD. This source was chosen because it offers practical insights real-world barriers such as cost and insurance limitations while emphasizing the importance of provider and patient education to diabetic patients like William.
The use of Artificial Intelligence (AI) in insulin pumps is a great step in treating uncontrolled type 2 diabetes. AI can study insulin dosing trends and use current glucose levels to model changes and automatically change insulin delivery to minimize the possibility of hypo- or hyperglycemia. To nurses, AI-assisted insulin pump systems reduce the workload in manual insulin adjustment and records, enabling them to devote more attention to the patients. These systems will improve clinical decision-making, as they will give timely alerts and personalized insights. In general, insulin pumps enabled with AI facilitate more accurate, anticipatory care, enhance patient safety, and enhance interdisciplinary cooperation in diabetes care.
Sorokin, D. Yu., Trufanova, E. S., Rebrova, O. Yu., Bezlepkina, O. B., & Laptev, D. N. (2024). Clinical decision support system based on artificial intelligence for adjusting insulin pump parameters in children with type 1 diabetes mellitus. Diabetes Mellitus, 27(3), 242–253. https://doi.org/10.14341/dm13167
The current paper is dedicated to the development and clinical testing of an AI-powered Clinical Decision Support System (CDSS) that aims to maximize insulin pump settings in children with type 1 diabetes. It shows how AI can individualize insulin treatment by using large data and forecasting glucose patterns, thus helping to achieve improved glycemic control. The research demonstrates that suggestions created by the CDSS tend to be similar to those produced by clinicians, which confirms its potential to facilitate decision-making.
In the case of nurses and interdisciplinary teams, the technology would relieve them of the manual work of insulin adjustments, increase the efficiency of the workflow, and provide the opportunity to implement timely and data-driven interventions. It encourages regular care provision, enables communication between team members and makes control and personalized treatment possible. The article was chosen due to the fact that it demonstrates an actual use of AI in managing diabetes in children and how this kind of innovations has the potential to make chronic disease management more precise, efficient, and consistent, particularly in the context of interdisciplinary care.
The five reviewed articles highlight the clinical and operational benefits of insulin pumps, especially AI-enhanced systems, in managing Type 1 and Type 2 diabetes. Jendle and Reznik (2023) and Pauley et al. (2022) show improved glycemic control and reduced complications, while Yeh et al. (2021) support safe inpatient pump use with clear protocols. Marks et al. (2022) address barriers like cost and training, stressing interdisciplinary collaboration, and Sorokin et al. (2024) demonstrate how AI-driven pumps reduce staff burden and improve care efficiency.
Organizational factors such as strong leadership, staff training, digital infrastructure, and a culture of innovation are key to adoption. For nurses and care teams, these pumps streamline decision-making, support timely interventions, and enhance patient safety, making them a practical, evidence-based solution for chronic disease care. AI-enhanced insulin pump systems improve patient outcomes, reduce clinical workload, and support timely interventions. Their adoption is justified by increased care efficiency, safety, and alignment with value-based healthcare goals.
Jendle, J., & Reznik, Y. (2023). Use of insulin pumps and closed‐loop systems among people living with diabetes: A narrative review of clinical and cost‐effectiveness to enable access to technology and meet the needs of payers. Diabetes Obesity and Metabolism, 25(S2), 21–32. https://doi.org/10.1111/dom.15087
Marks, B. E., Williams, K. M., Sherwood, J. S., & Putman, M. S. (2022). Practical aspects of diabetes technology use: Continuous glucose monitors, insulin pumps, and automated insulin delivery systems. Journal of Clinical & Translational Endocrinology, 27, 100282. https://doi.org/10.1016/j.jcte.2021.100282
Pauley, M. E., Tommerdahl, K. L., Snell-Bergeon, J. K., & Forlenza, G. P. (2022). Continuous glucose monitor, insulin pump, and automated insulin delivery therapies for type 1 diabetes: An update on potential for cardiovascular benefits. Current Cardiology Reports, 24(12), 2043–2056. https://doi.org/10.1007/s11886-022-01799-x
Sorokin, D. Yu., Trufanova, E. S., Rebrova, O. Yu., Bezlepkina, O. B., & Laptev, D. N. (2024). Clinical decision support system based on artificial intelligence for adjusting insulin pump parameters in children with type 1 diabetes mellitus. Diabetes Mellitus, 27(3), 242–253. https://doi.org/10.14341/dm13167
Yeh, T., Yeung, M., & Mendelsohn Curanaj, F. A. (2021). Managing patients with insulin pumps and continuous glucose monitors in the hospital: To wear or not to wear. Current Diabetes Reports, 21(2), 7. https://doi.org/10.1007/s11892-021-01375-7
